Bloom Energy's fuel cells cost twice as much as alternative power sources and are less reliable. The product also comes straight out of China, undercutting its appeal. x.com
Masa’s Son
Non-Consensus Long/Short Technology Investor
Bloom Energy's claims of ample capacity and reliability are contradicted by unverified expert procurement views from a double-digit-GW buyer. Management says it can deliver 5 GW a year and is not capacity- or supply-constrained, but an expert says solid oxide fuel cells are ruled out for current data centers on limited capacity and long lead times. Experts also cite unvalidated 5-10-year performance, possible sharp degradation after two years and scandium supply risk, which Bloom rejects. x.com x.com
Bloom Energy's demand may not become revenue when customers struggle to secure financing. Capital is difficult to raise in this climate; a reading of management's AI discussion also points to permitting, local opposition and customer credit as obstacles despite robust demand. Even after good earnings, the shares did not look very bullish. x.com x.com
Bloom Energy might be a short because incremental power capacity from China, whether new or refurbished turbines, is really bad for quick fixes like fuel cells, which produce far less power per unit. Dongfang Electric earns most of its money from coal boilers and nuclear steam turbines, with data centers a small new business. x.com x.com
Bloom Energy could look cheap if it hits its revenue targets amid exploding demand for on-site power. Revenue is projected at $4.5B in 2026 and $16B by 2029, implying 3.5x 2029 sales at a $56B market cap. It ranks alongside Forgent Power Solutions, perhaps better, as a buy at current levels. x.com x.com
FuelCell Energy's bull case rests on upside-only valuation logic, with investors anchoring to Bloom Energy until the sky is the limit, a sign of paying too much. Until FuelCell actually makes money, dilution is its business model, and dilution and opportunity costs can eat away even great upside. 2G Energy, a profitable German behind-the-meter small cap with a large backlog, several growth drivers, a cheaper valuation and no dilution problem, is preferred despite lower upside. x.com
Eos Energy, Fluence and FuelCell Energy are best avoided because capital-intensive energy technology requires super-high capex. These small companies have no way to compete with industrial giants that have far greater borrowing power. Bloom Energy is the exception, with lower capitalization and a unique product delivered within 60-90 days of contract signing. x.com
Bloom Energy solves power-development bottlenecks, a reason to own its shares. Object Zero lists land, permits, grid access, equipment, fuel security and community political power among the constraints, and says the remaining development sites keep getting worse. x.com
Bloom Energy's revenue is growing faster than cash collection. Q3 sales reached $1.24bn and the 2026 guide rose to $4.4-4.6bn, yet operating cash flow was -$27m despite $309m from customer deposits and deferred revenue. Contract assets rose $430m in the quarter and from $241m to $859m year to date. Its largest customer fell to 43% of revenue, but the second, at 26%, is a related party. Management calls the cash gap billing timing; Q4 cash flow tests that explanation. x.com x.com x.com
Bloom Energy is a great business priced as if it can't miss, at roughly 22x sales, so it now has to grow into its multiple. Per @StockSavvyShay, product revenue more than tripled in a year as Bloom's fuel cells deploy onsite in months versus nearly five years for grid interconnection. But crushing earnings and growing into a multiple are two very different problems, and the stock had already nearly halved from its June high going into the report. x.com
Bloom Energy looks more appealing after beating earnings estimates by a wide margin while trading at about 55 times earnings near $200. The market paid $350 in June, but the company now earns far more than expected despite a 33% share-price drawdown. x.com
Bloom Energy's valuation has come unhinged from fundamentals, drawing most of its premium from being a default high-beta AI trade. Nearly all its value rests on a backlog that deserves an execution-risk discount, including scandium sourcing: China owns about 70-90% of a 30-40-ton-a-year market, and Bloom is reportedly the largest consumer. The short report was opportunistic, scandium prices are muted, Bloom could likely pass on higher costs, and a full Chinese cutoff is far from the base case. … Show more